Trials / Recruiting
RecruitingNCT06039111
Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma
Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma: The IGNITE-V Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 58 (estimated)
- Sponsor
- Hamilton Health Sciences Corporation · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to confirm prospectively if the use of near infrared-indocyanine green (NIR-ICG) alone offers similar accuracy and sensitivity to the gold standard dual technique for sentinel lymph node detection in early stage vulvar cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ICG alone | SLNs will be detected with ICG alone, labelled as such, and subsequent to that tested with Gamma probe for accuracy |
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2026-05-30
- Completion
- 2026-11-30
- First posted
- 2023-09-15
- Last updated
- 2026-04-13
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06039111. Inclusion in this directory is not an endorsement.